EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Whole-Blood Copper Concentrations in Patients with Atrial Fibrillation According to Amiodarone Use: An Exploratory Study

Anna Olasińska-Wiśniewska, Tomasz Urbanowicz, Weronika Gościniak, Anetta Hanć, Wojciech Seniuk, Kevser Gülcihan Balcı, Dagmara Tritt, Filip Waśniewski, Rafał Górniak, Krzysztof Błaszyk

Nutrients · 11.11.2026 · 18 (22) · 3738

DOI: 10.3390/nu18223738 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 11.11.2026. Verfasst von Anna Olasińska-Wiśniewska und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Trace elements are essential for cardiovascular physiology, and their systemic imbalance has been linked to cardiovascular diseases and pharmacological therapies. However, the relationship between amiodarone therapy and whole-blood elemental profiles in patients with atrial fibrillation (AF) remains unclear.

Objectives

This exploratory study evaluated whole-blood elemental concentrations in AF patients with and without amiodarone treatment.

Methods

This single-center observational study included 51 AF patients (32 males, 62.8%; median (Q1–Q3) age of 71 (60–76) years) referred for catheter ablation. Whole-blood concentrations of 12 elements were compared in the amiodarone (n =18) and non-amiodarone (n = 33) subgroups. A subgroup analysis restricted to patients with predefined comorbidities was performed.

Results

After correction for multiple comparisons, patients receiving amiodarone had higher copper and cobalt concentrations and lower rubidium concentrations (q = 0.01, 0.02, and 0.04, respectively). Amiodarone use remained associated with higher copper concentration after multivariable adjustment (B = 86.3 µg/L, 95% CI 25.3–147.3; p = 0.007), with a similar bootstrap estimate. Adjusted associations for cobalt and rubidium were not statistically significant in the full sample. Among patients with predefined comorbidities, the differences in copper, cobalt, and lead remained significant after correction.

Conclusions

Amiodarone use was associated with higher whole-blood copper concentrations after adjustment for selected demographic and clinical characteristics. This association may partly reflect underlying cardiovascular disease burden, although the contributions of disease characteristics and treatment exposure remain uncertain. These findings are hypothesis-generating and do not establish causality.

Zitieren

APA

Olasińska-Wiśniewska, A., Urbanowicz, T., Gościniak, W., Hanć, A., Seniuk, W., Balcı, K. G., Tritt, D., Waśniewski, F., Górniak, R., & Błaszyk, K. (2026). Whole-Blood Copper Concentrations in Patients with Atrial Fibrillation According to Amiodarone Use: An Exploratory Study. Nutrients, 18(22), 3738. https://doi.org/10.3390/nu18223738

Vancouver

Olasińska-Wiśniewska A, Urbanowicz T, Gościniak W, Hanć A, Seniuk W, Balcı KG, et al. Whole-Blood Copper Concentrations in Patients with Atrial Fibrillation According to Amiodarone Use: An Exploratory Study. Nutrients. 2026;18(22):3738. doi:10.3390/nu18223738

BibTeX
@article{OlasiskaWiniewska2026,
  author = {Olasińska-Wiśniewska, Anna and Urbanowicz, Tomasz and Gościniak, Weronika and Hanć, Anetta and Seniuk, Wojciech and Balcı, Kevser Gülcihan and Tritt, Dagmara and Waśniewski, Filip and Górniak, Rafał and Błaszyk, Krzysztof},
  title = {Whole-Blood Copper Concentrations in Patients with Atrial Fibrillation According to Amiodarone Use: An Exploratory Study},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3738},
  doi = {10.3390/nu18223738}
}
Kostenlos starten →